The Marijuana Power Trio

These three companies provide you with three chances to make massive gains through marijuana investing. You are receiving this email because you subscribed to Outsider Club. [Click here]( to manage your e-mail preferences. [Outsider Club logo] The Marijuana Power Trio By Ryan Stancil Written Aug. 03, 2019 Three Wise Men. Three-Act Structures. Three Wishes. Three is a number that has persisted in human culture for as long as anyone can remember. It has been associated with religion, popular culture, math and science, sports, and a number of other fields. I’m willing to bet that, right now, without much thought, you can come up with any number of trios. But can you think of any that have to do with medicine or finance and investing? It’s perfectly fine if you can’t, because there is only one trio you need to know about today when it comes to those areas. And it has to do with marijuana. [Cannabis Is Taking Over Big Pharma... Three Cannabis Stocks to Buy Now]( For decades, big pharmaceutical companies have known about the medical benefits of cannabis and worked very hard to keep that information from ever going public. But now the last government blocks are crumbling and cannabis is bursting onto the scene. [THREE tiny cannabis companies]( are set to grow 80X thanks to the cannabis market's new freedom. The History and Details Behind the Three This is something that isn’t well known, but up until recently, the U.S. government had a tight grip on the cannabis industry. It had to do with cannabidiol, the component of marijuana that can be used to treat medical conditions. Until recently, it was lumped in with THC, the part of marijuana that causes the high. It was likewise lumped in with hemp, which was illegal up until the passage of the Farm Bill last year. This all fell under [what was called Patent 507](, which is what gave the government the level of control it had. Well, that patent expired in April of this year, and with that expiration came the removal of hemp from the federal list of controlled substances. That, along with the increasingly widespread acceptance of CBD as a part of medical treatment, means that new markets are opening up. Firms in the cannabis space will be able to thrive very quickly over the next few years. And while there are a number of different companies sure to take advantage of this big cultural change, there are three in particular set to stand out above the rest. - The first company provides oils and capsules meant to treat a wide range of medical ailments. People use its products to treat everything from epilepsy, to stress, to sleep problems. It also provides a range of pet products that help with brain function, vision, and other health issues to allow animals to live long and healthy lives. - The second is a cannabis oil company focused on providing its customers with state-of-the-art vaporizers for consumption. It also has patents for what can best be described as “Cannabis K-Cups” as well as plans to get into the high-end edibles market. - The third is a biotech company whose purpose is to create products to license to businesses. Its ultimate aim is to improve the quality of life of anyone who uses its products. It wants to do this through its own patented therapeutics that it has been developing. One such patent claims to get CBD to 95% purity, which is the thing that could set it apart from the rest of the market. [Watch as I turn $99 into $100,000]( I just made 3,220% on a cannabis buyout — the biggest win of my career. But I’m far from done... The world’s most important companies (Coca-Cola, Heineken, and Molson Coors, to name a few) are pouring billions into cannabis... and I’ve found five cannabis stocks that are prime targets for this buyout frenzy. If these five stocks do just a fraction of what I’ve done before, you could still make 1,000% or more, turning every $10,000 you invest into $100,000. I’m charging just $99 for this breaking-news cannabis report — [click here to get your copy.]( This is an emerging market, and like most emerging markets you need to move fast if you want to catch the biggest gains. The three companies outlined above are three that Outsider Club’s Jimmy Mengel believes will outshine the rest when it comes to making money in the CBD market. He’s done it before. Previous pot stock recommendations have produced triple-digit returns. One recommendation led readers to a 3,375% gain. That’s not a typo. And now, Jimmy is about to do it again. In his latest report, you can [learn the names of these three companies]( and see exactly why they’re likely to rise above the rest. These three companies provide you with three chances to make massive gains through marijuana investing, [so click here to learn more today.]( Keep your eyes open, [ryan_stencil_sig] Ryan Stancil Contributing Editor, Outsider Club Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [New Tech Makes Schools and Summer Camps Safer]( [The Government Just Made a Huge Mistake]( [Gold: Six-Year Highs as America Dies]( [Buy Low Now]( [Mr. Dines: A Gold Bug In The Fed?]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2019, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.